Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparable 12-week and Superior 24-week Remission With Risankizumab vs Ustekinumab for Crohn’s-like Disease of the Pouch

Clinical Gastroenterology and Hepatology(2025)10.1016/j.cgh.2025.10.026Source: DataRank Database

Comparable 12-week and Superior 24-week Remission With Risankizumab vs Ustekinumab for Crohn’s-like Disease of the Pouch is a research paper published in Clinical Gastroenterology and Hepatology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.92)OA: closedTopics (11)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Darwin Jimenez ORCID,Justin Huang ORCID,Elizabeth A. Spencer ORCID,Maia Kayal ORCID

Live enrichment

PubMed:41207520 OpenAlex:https://openalex.org/W4416020591

National Institutes of Health

Grant: K23DK127241

Foundation for the National Institutes of Health

FWCI

0.92

Citation Percentile

0.8%

Citation Trend

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1542356525009358?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356525009358?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cgh.2025.10.026

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41207520

Fields of Study

Inflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersDermatology and Skin Diseases

Keywords

UstekinumabPouchUlcerative colitisProctocolectomyCrohn's diseasePouchitisCrohn diseaseComplete remission

Comparable 12-week and Superior 24-week Remission With Risankizumab vs Ustekinumab for Crohn’s-like Disease of the Pouch

FAIR Checklist

Authors (4)

Funding (2 grants)

Impact

Open Access

Topics